EP4724088A1 - Vaccin pour le traitement de l'amyloïdose - Google Patents
Vaccin pour le traitement de l'amyloïdoseInfo
- Publication number
- EP4724088A1 EP4724088A1 EP24730397.7A EP24730397A EP4724088A1 EP 4724088 A1 EP4724088 A1 EP 4724088A1 EP 24730397 A EP24730397 A EP 24730397A EP 4724088 A1 EP4724088 A1 EP 4724088A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- ttr
- peptide
- vaccine
- amino acids
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
Landscapes
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne un vaccin à base de peptides pour le traitement ou la prévention de l'amyloïdose héréditaire à transthyrétine (ATTR).
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23178124 | 2023-06-07 | ||
| EP23212300 | 2023-11-27 | ||
| PCT/EP2024/065817 WO2024251997A1 (fr) | 2023-06-07 | 2024-06-07 | Vaccin pour le traitement de l'amyloïdose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4724088A1 true EP4724088A1 (fr) | 2026-04-15 |
Family
ID=91375092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24730397.7A Pending EP4724088A1 (fr) | 2023-06-07 | 2024-06-07 | Vaccin pour le traitement de l'amyloïdose |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4724088A1 (fr) |
| CN (1) | CN121646476A (fr) |
| WO (1) | WO2024251997A1 (fr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010195710A (ja) * | 2009-02-25 | 2010-09-09 | Kumamoto Univ | アミロイド線維形成抑制剤及びその利用 |
| EP2953970A4 (fr) | 2013-02-08 | 2016-06-29 | Misfolding Diagnostics Inc | Anticorps anti-transthyrétine et leurs utilisations |
| WO2015092077A1 (fr) | 2013-12-20 | 2015-06-25 | Neurimmune Holding Ag | Thérapie de l'amyloïdose de la transthyrétine (ttr) à base d'anticorps, et anticorps d'origine humaine afférents |
| CN106574258B (zh) | 2014-01-29 | 2021-03-30 | Km生物医药股份公司 | 抗-运甲状腺素蛋白人源化抗体 |
| KR102240417B1 (ko) | 2014-01-29 | 2021-04-13 | 케이엠 바이올로직스 가부시키가이샤 | 항-트랜스티레틴 인간 항체 |
| CN111315213B (zh) | 2017-10-06 | 2023-09-12 | 普罗塞纳生物科学有限公司 | 抗甲状腺素运载蛋白抗体 |
| WO2023099788A1 (fr) * | 2021-12-03 | 2023-06-08 | Neurimmune Ag | Nouveau dosage de puissance pour des médicaments à base d'anticorps et moyens utiles associés |
-
2024
- 2024-06-07 CN CN202480051335.8A patent/CN121646476A/zh active Pending
- 2024-06-07 WO PCT/EP2024/065817 patent/WO2024251997A1/fr not_active Ceased
- 2024-06-07 EP EP24730397.7A patent/EP4724088A1/fr active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN121646476A (zh) | 2026-03-10 |
| WO2024251997A1 (fr) | 2024-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102596236B (zh) | 抗原性Tau肽及其用途 | |
| TWI355390B (en) | Immunogenic peptide carrier conjugates and methods | |
| TW202208409A (zh) | 用於治療阿茲海默症之多抗原決定基疫苗 | |
| JP5792630B2 (ja) | Ｐａｎ−ｄｒ結合ポリペプチドおよびその使用 | |
| CN105085684B (zh) | Pcsk9靶向重组疫苗设计及其应用 | |
| US12161710B2 (en) | Malaria immunogen and methods for using same | |
| EP3615060A1 (fr) | Peptides antigéniques de vhs et vaccins protéiques de vhs | |
| JP2023541669A (ja) | アルツハイマー病の処置のためのβ－アミロイドワクチン | |
| JP6352251B2 (ja) | Ｃｒｍ１９７担体タンパク質に結合したｈｉｖｇｐ４１ペプチドを含む免疫原性化合物 | |
| CN117751132A (zh) | 用于治疗阿尔兹海默氏病的tau疫苗 | |
| WO2024251997A1 (fr) | Vaccin pour le traitement de l'amyloïdose | |
| EP4654992A1 (fr) | Compositions immunogènes à base de peptide tau et de peptide bêta-amyloïde et procédés associés | |
| CA2696068A1 (fr) | Compositions et procedes pour le traitement et la prophylaxie de l'hypertension | |
| TWI823051B (zh) | 針對垂體腺苷酸環化酶激活胜肽的胜肽免疫原及其預防和治療偏頭痛的製劑 | |
| JP5960064B2 (ja) | ヒトプロガストリンペプチドに対する免疫原性組成物 | |
| EP3658575A1 (fr) | Vaccin antipaludique | |
| US12121574B2 (en) | Malaria immunogen and methods for using same | |
| EP4554618A2 (fr) | Constructions immunogènes de peptide tau | |
| JP2026083278A (ja) | アルツハイマー病の処置のためのマルチエピトープワクチン | |
| US20220023421A1 (en) | Methods for eliciting selective humoral responses | |
| WO2024249626A1 (fr) | Trimères en tandem triple de l'enveloppe du vih-1 et leur utilisation | |
| EA048154B1 (ru) | Иммуногенные соединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20260106 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |